Chainitikun, S., Long, J. P., Rodriguez-Bautista, R., Iwase, T., Tripathy, D., Fujii, T., & Ueno, N. T. (2020). The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Breast Cancer Res Treat.

Chainitikun, Sudpreeda, James P. Long, Ruben Rodriguez-Bautista, Toshiaki Iwase, Debu Tripathy, Takeo Fujii, and Naoto T. Ueno. "The Efficacy of First-line Chemotherapy in Endocrine-resistant Hormone Receptor-positive (HR+), Human Epidermal Growth Factor Receptor 2-negative (HER2-) Metastatic Breast Cancer." Breast Cancer Res Treat 2020.

Chainitikun, Sudpreeda, et al. "The Efficacy of First-line Chemotherapy in Endocrine-resistant Hormone Receptor-positive (HR+), Human Epidermal Growth Factor Receptor 2-negative (HER2-) Metastatic Breast Cancer." Breast Cancer Res Treat 2020.